Cargando…

Strategies for active and passive pediatric RSV immunization

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children worldwide, with the most severe disease occurring in very young infants. Despite half a century of research there still are no licensed RSV vaccines. Difficulties in RSV vaccine development stem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eichinger, Katherine M., Kosanovich, Jessica L., Lipp, Madeline, Empey, Kerry M., Petrovsky, Nikolai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879001/ https://www.ncbi.nlm.nih.gov/pubmed/33623860 http://dx.doi.org/10.1177/2515135520981516

Ejemplares similares

Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection
por: Eichinger, Katherine M., et al.
Publicado: (2020)

Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulation
por: Eichinger, Katherine M., et al.
Publicado: (2022)

Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB/c mice born to PreF-vaccinated dams
por: Kosanovich, Jessica L., et al.
Publicado: (2023)

Data describing IFNγ-mediated viral clearance in an adult mouse model of respiratory syncytial virus (RSV)
por: Eichinger, Katherine M., et al.
Publicado: (2017)

RAGE contributes to allergen driven severe neutrophilic airway inflammation via NLRP3 inflammasome activation in mice
por: Killian, Katherine N., et al.
Publicado: (2023)

Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice
por: Eichinger, Katherine M., et al.
Publicado: (2015)

In vitro and in vivo evaluation of cerium oxide nanoparticles in respiratory syncytial virus infection
por: Patel, Akhil, et al.
Publicado: (2022)

Neonatal vaccine effectiveness and the role of adjuvants
por: Sakala, Isaac G., et al.
Publicado: (2019)

Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity
por: Stewart, Erica, et al.
Publicado: (2019)

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization
por: Raghunandan, Rama, et al.
Publicado: (2014)

Modulation of host adaptive immunity by hRSV proteins
por: Espinoza, Janyra A, et al.
Publicado: (2014)

Immunity to RSV in Early-Life
por: Lambert, Laura, et al.
Publicado: (2014)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
por: Gatt, Dvir, et al.
Publicado: (2023)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2022)

Strategies for Control of Pandemic Influenza: Active and Passive Immunization
por: Nguyen, Huan H.
Publicado: (2011)

Correction: Stewart et al. Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity. Microorganisms 2019, 7, 255
por: Stewart, Erica, et al.
Publicado: (2022)

Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
por: Andrade, Catalina A., et al.
Publicado: (2020)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

Socioeconomic Impact of RSV Hospitalization
por: Young, Michal, et al.
Publicado: (2021)

Immunopathology of RSV: An Updated Review
por: Bergeron, Harrison C., et al.
Publicado: (2021)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

Impact of the 2014 American Academy of Pediatrics Policy on RSV Hospitalization in Preterm Infants in the United States
por: Goldstein, Mitchell, et al.
Publicado: (2021)

How RSV Proteins Join Forces to Overcome the Host Innate Immune Response
por: Van Royen, Tessa, et al.
Publicado: (2022)

Immunity Cell Responses to RSV and the Role of Antiviral Inhibitors: A Systematic Review
por: Churiso, Gemechu, et al.
Publicado: (2022)

Protective and dysregulated T cell immunity in RSV infection()
por: Openshaw, Peter J, et al.
Publicado: (2013)

Interferon signaling drives epithelial metabolic reprogramming to promote secondary bacterial infection
por: Carreno-Florez, Grace P., et al.
Publicado: (2023)

WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use
por: Sparrow, Erin, et al.
Publicado: (2022)

Pediatric RSV-Associated Hospitalizations Before and During the COVID-19 Pandemic
por: Bourdeau, Malou, et al.
Publicado: (2023)

Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
por: Petrovsky, Nikolai
Publicado: (2015)

Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection
por: Guerra-Maupome, Mariana, et al.
Publicado: (2019)

RSV infection without ribavirin treatment in pediatric hematopoietic stem cell transplantation
por: El-Bietar, J, et al.
Publicado: (2016)

The Contribution of Neutrophils to the Pathogenesis of RSV Bronchiolitis
por: Sebina, Ismail, et al.
Publicado: (2020)

Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants
por: Wilkins, Deidre, et al.
Publicado: (2023)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

Editorial: Neonatal host immune responses to pulmonary infections
por: Empey, Kerry M., et al.
Publicado: (2023)

Exploring the Immune Response against RSV and SARS-CoV-2 Infection in Children
por: da Silva, Rafaela Pires, et al.
Publicado: (2023)

Severity and Cost of RSV Hospitalization Among US Preterm Infants Following the 2014 American Academy of Pediatrics Policy Change
por: Krilov, Leonard R., et al.
Publicado: (2021)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017)

Endocannabinoid engagement of CB(2) regulates RSV-induced immunity
por: Kaplan, Barbara L. F.
Publicado: (2018)

Correlative outcomes of maternal immunization against RSV in cotton rats
por: Blanco, Jorge C. G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t90l1e4rvsdp9cvpqvfoubk3mg